Natalizumab for active Crohn's disease.
Lew
Edward A
EA
Stoffel
Elena Martinez
EM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D000069442:Natalizumab; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab